All In MedTech

FDA Clearance Tracker · P080032-S006

ALAIR BRONCHIAL THERMOPLASTY SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 7, 2011 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 7, 2011

Approved

Time to decision

55 days

Received Feb 11, 2011. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P080032-S006
Device name
ALAIR BRONCHIAL THERMOPLASTY SYSTEM
Applicant location
Sunnyvale, CA
Received
Feb 11, 2011
Decided
Apr 7, 2011
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol - OSB
Original approval
P080032

Device type

Device class
Class III

Every decision under product code OOY

FDA's approval statement

As written in FDA's record.

APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.